Dr. Robert E. Loewenstein, MD

Dr. Loewenstein practices at Robert Wood Johnson University Hospital Somerset in Somerville, New Jersey, part of RWJBarnabas Health.

Dr. Loewenstein's NPI, 1750475687, was assigned on October 3, 2006. Dr. Loewenstein graduated from Rutgers New Jersey Medical School in 1996. Dr. Loewenstein holds New Jersey license 25MA07192400.

Dr. Loewenstein's primary practice is Robert Wood Johnson University Hospital Somerset, at 110 Rehill Ave, Somerville, NJ 08876 in Somerset County. The practice phone is (908) 685-2200.

Dr. Loewenstein's primary practice is Robert Wood Johnson University Hospital Somerset in Somerville, New Jersey, part of RWJBarnabas Health. Dr. Loewenstein is also affiliated with Heights University Hospital. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Loewenstein to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Loewenstein practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Loewenstein's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Loewenstein is licensed in New Jersey.

CMS data shows 832 Medicare services from Dr. Loewenstein across 5 procedure codes in 2024, for 591 Medicare patients. Medicare paid $82,877 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 591 Medicare patients who saw Dr. Loewenstein in 2024. The largest group is 75 to 84, with 185 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Loewenstein's median patient age at 64, with 53% women.

In 2024, Dr. Loewenstein wrote 193 Medicare Part D claims for 121 patients. 89% of them were for generic drugs. CMS names the drug for 55 of them, across 3 drugs with 11 or more claims each, at $362 in total drug cost. In 2023, CMS named 38 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Loewenstein for performance year 2024, reported as part of a group. Dr. Loewenstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Dr. Loewenstein from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $87.

Dr. Loewenstein graduated from Rutgers New Jersey Medical School in 1996.